Keep Me Logged In
The results of Vertex's clinical cystic fibrosis test was among the most anticipated events in the biotech space this year. Meg Tirrell has more on what the breakthrough means for patients and investors.
Got a confidential news tip? We want to hear from you.
Sign up for free newsletters and get more CNBC delivered to your inbox
© 2018 CNBC LLC. All Rights Reserved. A Division of NBCUniversal
Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.
Data also provided by